1. Home
  2. FULC vs KINS Comparison

FULC vs KINS Comparison

Compare FULC & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • KINS
  • Stock Information
  • Founded
  • FULC 2015
  • KINS 1886
  • Country
  • FULC United States
  • KINS United States
  • Employees
  • FULC N/A
  • KINS N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • KINS Property-Casualty Insurers
  • Sector
  • FULC Health Care
  • KINS Finance
  • Exchange
  • FULC Nasdaq
  • KINS Nasdaq
  • Market Cap
  • FULC 221.5M
  • KINS 197.1M
  • IPO Year
  • FULC 2019
  • KINS N/A
  • Fundamental
  • Price
  • FULC $3.96
  • KINS $15.37
  • Analyst Decision
  • FULC Hold
  • KINS Strong Buy
  • Analyst Count
  • FULC 10
  • KINS 1
  • Target Price
  • FULC $7.44
  • KINS $6.50
  • AVG Volume (30 Days)
  • FULC 1.0M
  • KINS 330.8K
  • Earning Date
  • FULC 02-25-2025
  • KINS 11-12-2024
  • Dividend Yield
  • FULC N/A
  • KINS N/A
  • EPS Growth
  • FULC N/A
  • KINS N/A
  • EPS
  • FULC N/A
  • KINS 1.34
  • Revenue
  • FULC $80,871,000.00
  • KINS $149,645,312.00
  • Revenue This Year
  • FULC $2,821.96
  • KINS N/A
  • Revenue Next Year
  • FULC N/A
  • KINS $15.56
  • P/E Ratio
  • FULC N/A
  • KINS $11.50
  • Revenue Growth
  • FULC 2987.86
  • KINS 3.44
  • 52 Week Low
  • FULC $2.86
  • KINS $2.40
  • 52 Week High
  • FULC $13.70
  • KINS $18.08
  • Technical
  • Relative Strength Index (RSI)
  • FULC 41.64
  • KINS 52.89
  • Support Level
  • FULC $3.93
  • KINS $13.25
  • Resistance Level
  • FULC $5.17
  • KINS $14.99
  • Average True Range (ATR)
  • FULC 0.30
  • KINS 0.85
  • MACD
  • FULC -0.13
  • KINS -0.07
  • Stochastic Oscillator
  • FULC 3.97
  • KINS 75.99

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About KINS Kingstone Companies Inc.

Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.

Share on Social Networks: